DuPont de Nemours, Inc. (NYSE:DD) Receives Average Rating of “Moderate Buy” from Brokerages

DuPont de Nemours, Inc. (NYSE:DD) has earned an average recommendation of “Moderate Buy” from the seventeen ratings firms that are presently covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, four have given a hold rating and twelve have assigned a buy rating to the company. The average 1-year price objective among analysts that have updated their coverage on the stock in the last year is $165.40.

A number of equities research analysts have weighed in on DD shares. Deutsche Bank Aktiengesellschaft boosted their target price on shares of DuPont de Nemours from $174.00 to $180.00 and gave the stock a “buy” rating in a report on Thursday, May 7th. Royal Bank Of Canada raised their target price on DuPont de Nemours from $168.00 to $180.00 and gave the stock an “outperform” rating in a research report on Monday, May 11th. Zacks Research cut DuPont de Nemours from a “strong-buy” rating to a “hold” rating in a report on Friday, July 17th. The Goldman Sachs Group increased their target price on shares of DuPont de Nemours from $53.00 to $159.00 and gave the company a “neutral” rating in a research report on Thursday, June 25th. Finally, Morgan Stanley upped their price objective on shares of DuPont de Nemours from $132.00 to $156.00 and gave the company an “equal weight” rating in a research note on Tuesday, April 28th.

DuPont de Nemours Trading Down 2.2%

Shares of DD stock opened at $144.07 on Friday. DuPont de Nemours has a twelve month low of $87.26 and a twelve month high of $157.98. The stock’s fifty day simple moving average is $139.76 and its 200 day simple moving average is $140.53. The company has a quick ratio of 2.11, a current ratio of 2.43 and a debt-to-equity ratio of 0.23. The firm has a market capitalization of $19.45 billion, a P/E ratio of 320.19, a P/E/G ratio of 1.37 and a beta of 1.06.

DuPont de Nemours (NYSE:DD) last announced its quarterly earnings results on Tuesday, August 4th. The basic materials company reported $1.88 EPS for the quarter, beating analysts’ consensus estimates of $1.76 by $0.12. The firm had revenue of $1.82 billion for the quarter, compared to analyst estimates of $1.81 billion. DuPont de Nemours had a return on equity of 6.92% and a net margin of 0.67%.The business’s revenue for the quarter was up 4.0% on a year-over-year basis. During the same period last year, the firm posted $1.12 earnings per share. DuPont de Nemours has set its Q3 2026 guidance at 1.800-1.900 EPS. As a group, sell-side analysts predict that DuPont de Nemours will post 7.25 EPS for the current fiscal year.

DuPont de Nemours Cuts Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 15th. Stockholders of record on Monday, August 31st will be given a $0.60 dividend. The ex-dividend date of this dividend is Monday, August 31st. This represents a $2.40 annualized dividend and a dividend yield of 1.7%. DuPont de Nemours’s dividend payout ratio (DPR) is 533.33%.

Hedge Funds Weigh In On DuPont de Nemours

Institutional investors have recently made changes to their positions in the stock. Palisade Asset Management LLC bought a new stake in DuPont de Nemours in the 3rd quarter valued at about $26,000. Imprint Wealth LLC acquired a new position in DuPont de Nemours during the third quarter worth $27,000. Basepoint Wealth LLC acquired a new position in DuPont de Nemours during the fourth quarter worth $28,000. Nalls Sherbakoff Group LLC acquired a new position in shares of DuPont de Nemours during the fourth quarter valued at about $29,000. Finally, Measured Wealth Private Client Group LLC bought a new stake in shares of DuPont de Nemours during the third quarter worth about $30,000. Institutional investors and hedge funds own 73.96% of the company’s stock.

About DuPont de Nemours

DuPont de Nemours (NYSE: DD) is a global science and engineering company that develops and supplies specialty materials, chemicals and industrial biosciences for a wide range of markets. Headquartered in Wilmington, Delaware, the company traces its origins to 1802 and has evolved through more than two centuries of innovation. In recent history DuPont participated in a major combination with Dow Chemical and subsequent reorganization that refocused the company on differentiated, specialty businesses built around science-based solutions.

DuPont’s operations center on advanced materials and technologies used by manufacturers and OEMs in industries such as transportation, electronics, construction, industrial manufacturing and worker safety.